Compound Detail
CHEMBL1921976
ORTERONEL 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1921976 |
| Name | ORTERONEL |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | OZPFIJIOIVJZMN-SFHVURJKSA-N |
5
Targets
10
Activities
2
Assay Types
0
PK Parameters
16
Publications
2
Known Names
4
Indications
1
Mechanisms
Molecular Properties
307.4
MW (Da)
2.04
ALogP
4
HBA
2
HBD
67.2
PSA (Ų)
0.76
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cytochrome P450 17A1 inhibitor | INHIBITOR | Steroid 17-alpha-hydroxylase/17,20 lyase | ✓ | ✓ |
Indications
Prostatic Neoplasms, Castration-Resistant Breast Neoplasms Neoplasms Prostatic Neoplasms
Activity Summary
IC50 9 meas. best 8.4
Kd 1 meas. best 7.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Steroid 21-hydroxylase CHEMBL2759 | IC50 | 8.4 | 6.855 | 4.0 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase CHEMBL3522 | IC50 | 8.4 | 7.005 | 4.0 | 4 |
| Steroid 17-alpha-hydroxylase/17,20 lyase CHEMBL3522 | Kd | 7.4 | 7.4 | 40.0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase CHEMBL4430 | IC50 | 7.32 | 7.32 | 48.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 4.85 | 4.85 | 14000.0 | 1 |
| Cytochrome P450 1A2 CHEMBL3356 | IC50 | 4.55 | 4.55 | 28000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32223238 | 10.1021/acs.jmedchem.9b01849 | Steroid 17-alpha-hydroxylase/17,20 lyase | 17 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cynomolgus monkey | 8 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Steroid 17-alpha-hydroxylase/17,20 lyase | 2 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 3A4 | 2 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2C9 | 2 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Unchecked | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | ADMET | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 1A2 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2A6 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2B6 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2C8 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2C19 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2D6 | 1 |
| 21978946 | 10.1016/j.bmc.2011.08.066 | Cytochrome P450 2E1 | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
Data from ChEMBL 36 via Core Engine